| 尼莫地平联合阿托伐他汀治疗血管性认知障碍的疗效观察 |
| |
| 引用本文： | 龙建庭,鲁玲,成明强,彭琼,游咏.尼莫地平联合阿托伐他汀治疗血管性认知障碍的疗效观察[J].卒中与神经疾病,2011,18(1):23-26. |
| |
| 作者姓名： | 龙建庭 鲁玲 成明强 彭琼 游咏 |
| |
| 作者单位： | 南华大学附属第一医院神经内科,421001 |
| |
| 基金项目： | 湖南省卫生厅医药卫生科研计划课题(B2006-112);湖南省卫生厅科研计划课题(B2010-044); 南华大学研究生创新课题(2010XCX14) |
| |
| 摘 要： | 目的探讨尼莫地平联合阿托伐他汀治疗血管性认知障碍的临床疗效及其不良反应。方法将96例血管性认知障碍患者随机分为对照组和治疗组,每组48例,再根据神经心理学评分将每组分为VCIND和VaD两个亚组。对照组给予了常规治疗＋安慰剂治疗,治疗组予尼莫地平＋阿托伐他汀治疗,尼莫地平30mg/d,1日3次,阿托伐他汀20mg/d,晚上1次,疗程均为6个月。采用MoCA和ADL评分对患者进行神经心理学评分。结果与同组治疗前相比,治疗组治疗6个月后MoCA和ADL评分分值明显提高（P〈0.01）;与对照组相比,治疗组治疗后MoCA和ADL评分值提高（P〈0.05）。对照组中VCIND患者MoCA和ADL较治疗前降低（P〈0.05）;治疗组中VCIND患者较治疗前及对照组MoCA和ADL分值明显提高（P〈0.01）,VaD患者无明显提高（P〉0.05）。2组均未见严重的不良反应。结论尼莫地平联合阿托伐他汀治疗血管性认知障碍的临床疗效较好,不良反应少。
|
| 关 键 词： | 尼莫地平 阿托伐他汀 血管性认知障碍 |
The efficacy of combiration therapy with nimodipine cand atorvastatin for the patients with vascular cognitive impairment |
| |
| Long Jianting,Lu Ling,Cheng Mingqiang,et al..The efficacy of combiration therapy with nimodipine cand atorvastatin for the patients with vascular cognitive impairment[J].Stroke and Nervous Diseases,2011,18(1):23-26. |
| |
| Authors: | Long Jianting Lu Ling Cheng Mingqiang |
| |
| Institution: | Long Jianting,Lu Ling,Cheng Mingqiang,et al.Department of Neurology,The First Affiliated Hospital of Nanhua University,Hengvaing 421001 |
| |
| Abstract: | Objective To observe the efficacy and safety of the combination therapy with nimodipine and atorvastatin for patients with vascular cognitive impairment(VCI).Methods Ninety-six patients with VCI were devided rardomizedly into intervention group,receiving nimodipin(90 mg/d) and atorvastatin(20 mg/d),and to control group,receiving placebno.Forty-eight participants were in each group.The sub-group of vascular cognitive impairment without dementia(VCIND) and vascular dementia(VaD) in intervention and control gr... |
| |
| Keywords: | Nimodipine Atorvastatin Vascular cognitive impairment |
| 本文献已被 CNKI 维普 万方数据 等数据库收录！ |
|
